Militia Capital Management LLC Purchases New Holdings in Sabra Healthcare REIT, Inc. $SBRA

Militia Capital Management LLC purchased a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 46,000 shares of the real estate investment trust’s stock, valued at approximately $885,000.

Other institutional investors have also recently made changes to their positions in the company. Rothschild Investment LLC boosted its holdings in shares of Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 889 shares during the last quarter. Smartleaf Asset Management LLC increased its holdings in Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 714 shares during the last quarter. Strengthening Families & Communities LLC acquired a new position in Sabra Healthcare REIT during the fourth quarter worth $29,000. Danske Bank A S acquired a new position in Sabra Healthcare REIT during the third quarter worth $30,000. Finally, Larson Financial Group LLC raised its position in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 553 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Analyst Upgrades and Downgrades

SBRA has been the subject of a number of recent analyst reports. Citizens Jmp increased their price target on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research note on Wednesday. Wells Fargo & Company boosted their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Weiss Ratings cut shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday. Finally, Barclays assumed coverage on Sabra Healthcare REIT in a report on Tuesday, July 7th. They set an “overweight” rating and a $21.00 price target for the company. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $22.25.

Sabra Healthcare REIT Stock Up 0.2%

SBRA opened at $22.03 on Friday. The stock’s fifty day simple moving average is $19.64 and its 200 day simple moving average is $19.82. Sabra Healthcare REIT, Inc. has a 1-year low of $17.17 and a 1-year high of $22.55. The stock has a market cap of $5.56 billion, a PE ratio of 34.97, a price-to-earnings-growth ratio of 1.63 and a beta of 0.65. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting the consensus estimate of $0.16. The company had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm’s revenue for the quarter was up 20.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, research analysts expect that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, May 15th. This represents a $1.20 annualized dividend and a yield of 5.4%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.